The pivotal role of DNMT1 in the regulation and stemness of CSLCs has been well documented in various tumors, including leukemia [41], breast cancer [42], hepatocelluar cancer [43], non-small-cell lung cancer [44], and pancreatic adenocarcinoma [45] and OS [46]. This evidence concerns the gene DNMT1 and breast carcinoma.